Lucid Diagnostics Inc. Q4 2025 Earnings Call Summary

Achieved record Q4 test volume of 3,664, exceeding the target range of 2,500 to 3,000, driven by improved sales team productivity and established market presence. Secured a U.S. Department of Veterans Affairs (VA) contract under the Federal Supply Schedule, validating the Medicare pricing of $938 and providing access to 9 million enrolled veterans. Identified a 'de facto' coverage pathway with UnitedHealthcare by leveraging endoscopy guidelines that list EsoGuard as an appropriate indicator for EGD pr ...